AU2002249155A1 - Thiazolamines and their use as tgf-beta inhibitors - Google Patents

Thiazolamines and their use as tgf-beta inhibitors

Info

Publication number
AU2002249155A1
AU2002249155A1 AU2002249155A AU2002249155A AU2002249155A1 AU 2002249155 A1 AU2002249155 A1 AU 2002249155A1 AU 2002249155 A AU2002249155 A AU 2002249155A AU 2002249155 A AU2002249155 A AU 2002249155A AU 2002249155 A1 AU2002249155 A1 AU 2002249155A1
Authority
AU
Australia
Prior art keywords
thiazolamines
tgf
beta inhibitors
inhibitors
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249155A
Inventor
Francoise Jeanne Gellibert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002249155A1 publication Critical patent/AU2002249155A1/en
Abandoned legal-status Critical Current

Links

AU2002249155A 2001-02-02 2002-01-31 Thiazolamines and their use as tgf-beta inhibitors Abandoned AU2002249155A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0102665.7 2001-02-02

Publications (1)

Publication Number Publication Date
AU2002249155A1 true AU2002249155A1 (en) 2002-08-19

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002356762A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003266058A1 (en) Antimicrobial composition and method for use
AU2002356664A1 (en) Beta-amino-alpha-cyanoacrylates and their use as herbicides
AU2002347614A1 (en) Antioxidant combination composition and use thereof
AU2002361861A1 (en) SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
AU2002305523A1 (en) Dioxanes and uses thereof
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2002343403A1 (en) Personal object holding device
AU2002356276A1 (en) Quinline derivates and their use as mek inhibitors
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002359694A1 (en) Compounds and methods
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
PL363544A1 (en) Piperazino-derivatives and their use as pde4 inhibitor
AU2002249978A1 (en) Polymers and use thereof as scale inhibitors
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2002249155A1 (en) Thiazolamines and their use as tgf-beta inhibitors
AU2002359869A1 (en) Pak5-related compositions and methods
AU2003245524A1 (en) Cryosurgery compositions and methods
AU2003255232A1 (en) Antigiardial agents and use thereof
AU2002259301A1 (en) Caspase inhibitors and uses thereof
AU2002223649A1 (en) Vegh inhibitors and their use
AU2002228426A1 (en) Neurotonin and use thereof